Scales to evaluate quality of medication management: Development and psychometric properties

Amanda C. Taylor; Gary R. Bond; Jack Tsai; Patricia B. Howard; Peggy El-Mallakh; Molly Finnerty; Edith Kealey; Britt Myrhol; Karin Kalk; Neal Adams; Alexander L. Miller

doi:10.1007/s10488-009-0209-z

Scales to evaluate quality of medication management: Development and psychometric properties

Amanda C. Taylor
, Gary R. Bond
, Jack Tsai
, Patricia B. Howard
, Peggy El-Mallakh
, Molly Finnerty
, Edith Kealey
, Britt Myrhol
, Karin Kalk
, Neal Adams
, Alexander L. Miller

College of Nursing

Producción científica: Article › revisión exhaustiva

6 Citas (Scopus)

Resumen

This paper describes the psychometric properties of two fidelity scales created as part of the Substance Abuse and Mental Health Services Administration (SAMHSA) sponsored medication management toolkit and their metric properties when used in 26 public mental health clinics with 50 prescribers. A 23-item scale, based on chart reviews, was developed to assess whether prescribers are following good medication practices, in conjunction with a 17-item scale to assess organizational support for and evaluation of prescriber adherence to recommended medication-related practices. Fundamental gaps in routine practice, including poor documentation of medication history and infrequent monitoring of symptoms and side effects were found.

Idioma original	English
Páginas (desde-hasta)	247-254
Número de páginas	8
Publicación	Administration and Policy in Mental Health and Mental Health Services Research
Volumen	36
N.º	4
DOI	https://doi.org/10.1007/s10488-009-0209-z
Estado	Published - jul 2009

Nota bibliográfica

Funding Information:
Mt. Sinai School of Medicine). Scale testing was funded by unrestricted educational grants from AstraZeneca, Bristol Myers Squibb, Janssen, Lilly, and Pfizer to Dr. Miller. Initial development of the scale was funded by a contract between Dartmouth Medical School and the Substance Abuse and Mental Health Services Administration for development of evidence-based practice toolkits, with the medication toolkit subcontracted to the University of Texas Health Science Center at San Antonio.

Financiación

Mt. Sinai School of Medicine). Scale testing was funded by unrestricted educational grants from AstraZeneca, Bristol Myers Squibb, Janssen, Lilly, and Pfizer to Dr. Miller. Initial development of the scale was funded by a contract between Dartmouth Medical School and the Substance Abuse and Mental Health Services Administration for development of evidence-based practice toolkits, with the medication toolkit subcontracted to the University of Texas Health Science Center at San Antonio.

Financiadores
Dartmouth Hitchcock Medical School
Substance Abuse and Mental Health Services Administration
Bristol-Myers Squibb
AstraZeneca
The University of Texas Health Science Center at San Antonio
Janssen Pharmaceuticals

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

Good health and well being

ASJC Scopus subject areas

Psychiatric Mental Health
Health Policy
Public Health, Environmental and Occupational Health
Psychiatry and Mental health

Acceder al documento

10.1007/s10488-009-0209-z

Otros archivos y enlaces

Citar esto

Taylor, A. C., Bond, G. R., Tsai, J., Howard, P. B., El-Mallakh, P., Finnerty, M., Kealey, E., Myrhol, B., Kalk, K., Adams, N., & Miller, A. L. (2009). Scales to evaluate quality of medication management: Development and psychometric properties. Administration and Policy in Mental Health and Mental Health Services Research, 36(4), 247-254. https://doi.org/10.1007/s10488-009-0209-z

@article{eab979c4196e421bae1cecbcef331681,

title = "Scales to evaluate quality of medication management: Development and psychometric properties",

abstract = "This paper describes the psychometric properties of two fidelity scales created as part of the Substance Abuse and Mental Health Services Administration (SAMHSA) sponsored medication management toolkit and their metric properties when used in 26 public mental health clinics with 50 prescribers. A 23-item scale, based on chart reviews, was developed to assess whether prescribers are following good medication practices, in conjunction with a 17-item scale to assess organizational support for and evaluation of prescriber adherence to recommended medication-related practices. Fundamental gaps in routine practice, including poor documentation of medication history and infrequent monitoring of symptoms and side effects were found.",

keywords = "Antipsychotics, Fidelity measurement, Medication management",

author = "Taylor, \{Amanda C.\} and Bond, \{Gary R.\} and Jack Tsai and Howard, \{Patricia B.\} and Peggy El-Mallakh and Molly Finnerty and Edith Kealey and Britt Myrhol and Karin Kalk and Neal Adams and Miller, \{Alexander L.\}",

note = "Funding Information: Mt. Sinai School of Medicine). Scale testing was funded by unrestricted educational grants from AstraZeneca, Bristol Myers Squibb, Janssen, Lilly, and Pfizer to Dr. Miller. Initial development of the scale was funded by a contract between Dartmouth Medical School and the Substance Abuse and Mental Health Services Administration for development of evidence-based practice toolkits, with the medication toolkit subcontracted to the University of Texas Health Science Center at San Antonio.",

year = "2009",

month = jul,

doi = "10.1007/s10488-009-0209-z",

language = "English",

volume = "36",

pages = "247--254",

number = "4",

}

Taylor, AC, Bond, GR, Tsai, J, Howard, PB, El-Mallakh, P, Finnerty, M, Kealey, E, Myrhol, B, Kalk, K, Adams, N & Miller, AL 2009, 'Scales to evaluate quality of medication management: Development and psychometric properties', Administration and Policy in Mental Health and Mental Health Services Research, vol. 36, n.º 4, pp. 247-254. https://doi.org/10.1007/s10488-009-0209-z

TY - JOUR

T1 - Scales to evaluate quality of medication management

T2 - Development and psychometric properties

AU - Taylor, Amanda C.

AU - Bond, Gary R.

AU - Tsai, Jack

AU - Howard, Patricia B.

AU - El-Mallakh, Peggy

AU - Finnerty, Molly

AU - Kealey, Edith

AU - Myrhol, Britt

AU - Kalk, Karin

AU - Adams, Neal

AU - Miller, Alexander L.

N1 - Funding Information: Mt. Sinai School of Medicine). Scale testing was funded by unrestricted educational grants from AstraZeneca, Bristol Myers Squibb, Janssen, Lilly, and Pfizer to Dr. Miller. Initial development of the scale was funded by a contract between Dartmouth Medical School and the Substance Abuse and Mental Health Services Administration for development of evidence-based practice toolkits, with the medication toolkit subcontracted to the University of Texas Health Science Center at San Antonio.

PY - 2009/7

Y1 - 2009/7

N2 - This paper describes the psychometric properties of two fidelity scales created as part of the Substance Abuse and Mental Health Services Administration (SAMHSA) sponsored medication management toolkit and their metric properties when used in 26 public mental health clinics with 50 prescribers. A 23-item scale, based on chart reviews, was developed to assess whether prescribers are following good medication practices, in conjunction with a 17-item scale to assess organizational support for and evaluation of prescriber adherence to recommended medication-related practices. Fundamental gaps in routine practice, including poor documentation of medication history and infrequent monitoring of symptoms and side effects were found.

AB - This paper describes the psychometric properties of two fidelity scales created as part of the Substance Abuse and Mental Health Services Administration (SAMHSA) sponsored medication management toolkit and their metric properties when used in 26 public mental health clinics with 50 prescribers. A 23-item scale, based on chart reviews, was developed to assess whether prescribers are following good medication practices, in conjunction with a 17-item scale to assess organizational support for and evaluation of prescriber adherence to recommended medication-related practices. Fundamental gaps in routine practice, including poor documentation of medication history and infrequent monitoring of symptoms and side effects were found.

KW - Antipsychotics

KW - Fidelity measurement

KW - Medication management

UR - https://www.scopus.com/pages/publications/67449152474

UR - https://www.scopus.com/pages/publications/67449152474#tab=citedBy

U2 - 10.1007/s10488-009-0209-z

DO - 10.1007/s10488-009-0209-z

M3 - Article

C2 - 19247828

AN - SCOPUS:67449152474

SN - 0894-587X

VL - 36

SP - 247

EP - 254

JO - Administration and Policy in Mental Health and Mental Health Services Research

JF - Administration and Policy in Mental Health and Mental Health Services Research

IS - 4

ER -

Scales to evaluate quality of medication management: Development and psychometric properties

Resumen

Nota bibliográfica

Financiación

ODS de las Naciones Unidas

ASJC Scopus subject areas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto